Rituximab can push the abnormal IgM protein up for a few weeks before bringing it down, which can thicken the blood when the level is already high. Hospitals prevent this differently: plasma exchange first, leaving rituximab out of the first cycles, or watching closely. No study has compared them, and the two guidelines that recommend acting grade their evidence as low.
What the guidelines say. The British Society for Haematology guideline (2022) says the introduction of rituximab should be deferred, or prophylactic plasmapheresis performed, when IgM or M-protein is above 40 g/L, and grades this C1. The American Society for Apheresis (2026) gives plasma exchange before rituximab its category I with grade 1C, and counts the evidence as 3 case series and 3 case reports, with no randomised or controlled trial; it also offers holding rituximab for 1 to 3 cycles until IgM is below 4 g/dL as the alternative.
The doubt. In his 2018 review, Gertz writes that it is unproven that pre-emptive plasma exchange in people without symptoms and an IgM above 5000 prevents complications when compared with close monitoring after rituximab and treatment if symptoms develop, and adds that many would not agree and do exchange first.
How often the flare happens. In an Eastern Cooperative Oncology Group study of rituximab given alone, IgM rose in 29 of 54 patients (54%), and no factor predicting the rise could be identified. The apheresis guideline puts the figure at 30% to 70% within 4 weeks.
What each choice costs. Plasma exchange usually needs a central line and an apheresis session. Holding rituximab changes the first cycles of treatment. Watching closely costs blood tests and depends on the person reporting symptoms early. Which route leads to fewer episodes of hyperviscosity has not been measured in any source read.
Shares the tags protocol-upgrade, upgrade:untested.
Shares the tags protocol-upgrade, upgrade:untested.
Shares the tags protocol-upgrade, upgrade:untested.
Shares the tags protocol-upgrade, upgrade:untested.
Shares the tags protocol-upgrade, upgrade:untested.
Shares the tags protocol-upgrade, upgrade:untested.
Shares the tags protocol-upgrade, upgrade:untested.
Shares the tags protocol-upgrade, upgrade:untested.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/